NO983509D0 - Taksanderivater med en pyridylsubstituert C13-sidekjede, fremstilling derav og anvendelse derav som antitumormidler - Google Patents

Taksanderivater med en pyridylsubstituert C13-sidekjede, fremstilling derav og anvendelse derav som antitumormidler

Info

Publication number
NO983509D0
NO983509D0 NO983509A NO983509A NO983509D0 NO 983509 D0 NO983509 D0 NO 983509D0 NO 983509 A NO983509 A NO 983509A NO 983509 A NO983509 A NO 983509A NO 983509 D0 NO983509 D0 NO 983509D0
Authority
NO
Norway
Prior art keywords
microtubules
pct
taxol
depolymerisation
mitosis
Prior art date
Application number
NO983509A
Other languages
English (en)
Other versions
NO983509L (no
Inventor
Ulrich Klar
Guenter Neef
Hermann Graf
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of NO983509D0 publication Critical patent/NO983509D0/no
Publication of NO983509L publication Critical patent/NO983509L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
NO983509A 1996-01-31 1998-07-30 Taksanderivater med en pyridylsubstituert C13-sidekjede, fremstilling derav og anvendelse derav som antitumormidler NO983509L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19605024A DE19605024A1 (de) 1996-01-31 1996-01-31 Neue selektive Taxane, Verfahren zu ihrer Herstellung und ihre pharmazeutische Verwendung
PCT/EP1997/000440 WO1997028156A1 (en) 1996-01-31 1997-01-31 Taxane derivatives having a pyridyl substituted c13 side chain, their preparation and their use as anti-tumor agents

Publications (2)

Publication Number Publication Date
NO983509D0 true NO983509D0 (no) 1998-07-30
NO983509L NO983509L (no) 1998-07-30

Family

ID=7785142

Family Applications (1)

Application Number Title Priority Date Filing Date
NO983509A NO983509L (no) 1996-01-31 1998-07-30 Taksanderivater med en pyridylsubstituert C13-sidekjede, fremstilling derav og anvendelse derav som antitumormidler

Country Status (26)

Country Link
US (1) US6162920A (no)
EP (1) EP0896577B1 (no)
JP (1) JP2001505527A (no)
KR (1) KR19990082151A (no)
CN (1) CN1073108C (no)
AT (1) ATE233757T1 (no)
AU (1) AU714313B2 (no)
BR (1) BR9708295A (no)
CA (1) CA2244746A1 (no)
CZ (1) CZ292504B6 (no)
DE (2) DE19605024A1 (no)
DK (1) DK0896577T3 (no)
ES (1) ES2192261T3 (no)
HK (1) HK1018778A1 (no)
HU (1) HUP9901027A3 (no)
IL (1) IL124951A (no)
NO (1) NO983509L (no)
PL (1) PL186796B1 (no)
PT (1) PT896577E (no)
RU (1) RU2163599C2 (no)
SK (1) SK101198A3 (no)
TR (1) TR199801415T2 (no)
TW (1) TW444015B (no)
UA (1) UA49007C2 (no)
WO (1) WO1997028156A1 (no)
ZA (1) ZA97847B (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7126003B2 (en) 2001-03-07 2006-10-24 Daiichi Pharmaceutical Co., Ltd. Method for producing 2-azetidinone derivative
US20040220655A1 (en) 2003-03-03 2004-11-04 Sinus Rhythm Technologies, Inc. Electrical conduction block implant device
CN1296391C (zh) * 2004-03-04 2007-01-24 中国人民解放军第二军医大学 氟代羧烷基环糊精醚类化合物及其制备方法和应用
CN107811971B (zh) 2004-05-03 2021-10-29 益普生生物制药公司 用于药物输送的脂质体
US8658203B2 (en) 2004-05-03 2014-02-25 Merrimack Pharmaceuticals, Inc. Liposomes useful for drug delivery to the brain
AU2013202947B2 (en) 2012-06-13 2016-06-02 Ipsen Biopharm Ltd. Methods for treating pancreatic cancer using combination therapies comprising liposomal irinotecan
US9717724B2 (en) 2012-06-13 2017-08-01 Ipsen Biopharm Ltd. Methods for treating pancreatic cancer using combination therapies
US11318131B2 (en) 2015-05-18 2022-05-03 Ipsen Biopharm Ltd. Nanoliposomal irinotecan for use in treating small cell lung cancer
ES2848118T3 (es) 2015-08-20 2021-08-05 Ipsen Biopharm Ltd Terapia de combinación que usa irinotecán liposomal y un inhibidor de PARP para el tratamiento del cáncer
TWI778942B (zh) 2015-08-21 2022-10-01 英商益普生生物製藥有限公司 使用包含微脂伊立替康（ｉｒｉｎｏｔｅｃａｎ）及奧沙利鉑（ｏｘａｌｉｐｌａｔｉｎ）之組合療法治療轉移性胰臟癌的方法
RU2732567C2 (ru) 2015-10-16 2020-09-21 Ипсен Биофарм Лтд. Стабилизированные фармацевтические композиции камптотецина
BR112019007844A2 (pt) 2016-11-02 2019-07-16 Ipsen Biopharm Ltd tratamento de câncer gástrico usando terapias de combinação compreendendo irinotecano lipossômico, oxaliplatina, 5-fluoroacila (e leucovorina)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5227400A (en) * 1991-09-23 1993-07-13 Florida State University Furyl and thienyl substituted taxanes and pharmaceutical compositions containing them
US5489601A (en) * 1991-09-23 1996-02-06 Florida State University Taxanes having a pyridyl substituted side-chain and pharmaceutical compositions containing them
PT690712E (pt) * 1993-03-22 2002-05-31 Univ Florida State Taxanos possuindo uma cadeia lateral substituida com piridilo
US5415869A (en) * 1993-11-12 1995-05-16 The Research Foundation Of State University Of New York Taxol formulation
FR2715307B1 (fr) * 1994-01-25 1996-04-05 Commissariat Energie Atomique Procédé de solubilisation dans un milieu aqueux d'agents antitumoraux de la famille du taxol, et cyclodextrines ramifiées utilisables pour cette solubilisation.
NZ288802A (en) * 1994-06-28 1998-05-27 Upjohn Co Ether taxol derivatives, preparation and pharmaceutical compositions thereof

Also Published As

Publication number Publication date
IL124951A (en) 2003-12-10
UA49007C2 (uk) 2002-09-16
AU714313B2 (en) 1999-12-23
CA2244746A1 (en) 1997-08-07
PT896577E (pt) 2003-06-30
WO1997028156A1 (en) 1997-08-07
ES2192261T3 (es) 2003-10-01
HUP9901027A2 (hu) 2001-05-28
RU2163599C2 (ru) 2001-02-27
DK0896577T3 (da) 2003-05-19
BR9708295A (pt) 1999-08-03
JP2001505527A (ja) 2001-04-24
PL328055A1 (en) 1999-01-04
CZ292504B6 (cs) 2003-10-15
EP0896577A1 (en) 1999-02-17
PL186796B1 (pl) 2004-02-27
HK1018778A1 (en) 2000-01-07
TW444015B (en) 2001-07-01
NO983509L (no) 1998-07-30
DE19605024A1 (de) 1997-08-07
AU1598497A (en) 1997-08-22
DE69719502T2 (de) 2004-02-19
HUP9901027A3 (en) 2001-08-28
ATE233757T1 (de) 2003-03-15
ZA97847B (en) 1997-08-04
CN1073108C (zh) 2001-10-17
CN1210535A (zh) 1999-03-10
TR199801415T2 (xx) 1998-10-21
DE69719502D1 (de) 2003-04-10
IL124951A0 (en) 1999-01-26
CZ242698A3 (cs) 1999-07-14
KR19990082151A (ko) 1999-11-15
US6162920A (en) 2000-12-19
EP0896577B1 (en) 2003-03-05
SK101198A3 (en) 1998-12-02

Similar Documents

Publication Publication Date Title
NO983509D0 (no) Taksanderivater med en pyridylsubstituert C13-sidekjede, fremstilling derav og anvendelse derav som antitumormidler
RU2213097C2 (ru) Гетероциклы в качестве ингибиторов адгезии лейкоцитов и vla-4-антагонистов
RU95108387A (ru) Дикетопиперазин, способ его получения, фармацевтическая композиция, применение дикетопиперазина
EA200100553A1 (ru) Замещенные бициклические производные, полезные в качестве противораковых агентов
RU94042922A (ru) Новые соединения, способы их получения, фармацевтическая композиция
EA199900641A1 (ru) Производные арилсульфонилгидроксамовой кислоты
ATE145337T1 (de) Verbindungen, zusammensetzungen und verfahren zum binden von bio-affektions-substanzen an oberflächenmembranen von bioteilchen
RU94039542A (ru) Производные пиперазина как антагонисты 5-нт-рецепторов, способ получения, фармацевтическая композиция
FI942075A0 (fi) Sappihappojohdannaisten tetratsolijohdannaisia, menetelmä niiden valmistamiseksi ja näiden yhdisteiden käyttö lääkeaineina
ES2187519T3 (es) 7-halogeno-y 7beta,8beta-metano-taxoles, uso antineoplasico y composiciones farmaceuticas que los contienen.
EA200200333A1 (ru) Новый класс веществ, вызывающих дифференцировку клеток и являющихся ингибиторами гистондеацетилазы, и способы их применения
HUP0203542A2 (en) 3(5)-amino-pyrazole derivatives, process for their preparation, their use and pharmaceutical compositions containing the same
RU94040859A (ru) Аминопроизводные оксо- и гидрокси-замещенных углеводородов, способы получения, фармацевтические композиции, способ ингибирования ретровирусной протеазы, способ лечения спида у млекопитающих
ES2168304T3 (es) Derivados del taxol.
FI962952A0 (fi) Delta 12,13-iso-taksolianalogit, niiden antineoplastinen käyttö ja niitä sisältävät farmaseuttiset koostumukset
ATE251624T1 (de) Granulatimide-derivate zur behandlung von krebs
JO1696B1 (en) Acetamide derivatives
RU94036745A (ru) Производные галантамина и фармацевтическая композиция
FI935800A0 (fi) Antidepressiva och mot Parkisons sjukdom verksamma foereningar
MY120318A (en) Mixture of primary fatty acids of high molecular weight obtained from sugar cane wax and its pharmaceutical uses.
AU1915499A (en) Multicatalytic protease inhibitors for use as anti-tumor agents
DE69917005D1 (de) Substituierte pyrrolobenzimidazolderivate zur entzündungshemmung
AU7385398A (en) Novel macrocyclic compounds as metalloprotease inhibitors
RU94014631A (ru) Производные 4-хиномиодигидропиридина, смесь их изомеров или отдельные изомеры и их соли
DZ3046A1 (fr) Hydroxamides d'acides 3-(arylsulfonylamino)-tétrahydropyranne-3-carboxyliques, procédé pour leur préparation et compositions pharmaceutiques les contenant.